Heart Failure Beat

About Heart Failure Beat

Each month, join the Heart Failure Society of America as we have candid conversations with heart failure clinicians on the topics they face on a daily basis. From breakthroughs in research and treatment to career development and growth, the Heart Failure Beat has you covered! If you’re a cardiology clinician, trainee, or just plain interested in hearing discussions about heart failure news from leading experts, this is the podcast for you!

Publisher

Heart Failure Society of America

Category

health & fitness · science

Language

en

Explicit

No

First episode

27 Apr 2020

Latest episode

25 Jun 2026

Latest episodes

52 episodes in the feed.

1. 

   25 Jun 2026

   HFmrEF: Finding a Compass in the Heart Failure "No Man's Land"

   Heart failure with mildly reduced ejection fraction (HFmrEF) affects up to 25% of patients with heart failure, yet many clinicians remain uncertain about how best to diagnose and treat it. In this episode, HFSA Scientific Statement co-authors Jane E. Wilcox, MD, and Barry A. Borlaug, MD, discuss the evidence, clinical implications, and key takeaways from the newly published HFSA Scientific Statement. Read the Scientific Statement: HFSA Scientific Statement: Heart Failure with Mildly Reduced Ejection Fraction

2. 

   21 May 2026

   A New Dawn in Inflammatory & Infiltrative Cardiomyopathies

   This month’s Heart Failure Beat episode explores the May 2026 special focus issue of the Journal of Cardiac Failure on infiltrative and inflammatory cardiomyopathies. Drs. Nisha A. Gilotra, Mathew Maurer and Emer Joyce discuss breakthroughs in amyloidosis, cardiac sarcoidosis, myocarditis, AI-driven diagnostics, emerging therapies, and the future of multidisciplinary care and research in these complex diseases.

3. 

   26 Mar 2026

   MRAs in HFpEF & HFmrEF: A Clinical Debate

   In this lively debate, heart failure pharmacists Stormi Gale, PharmD and Robert L Page II, PharmD examine the role of MRAs in HFpEF and HFmrEF. From trial data and cost considerations to CKM overlap and hyperkalemia risk, they explore whether finerenone represents a new pillar - or whether spironolactone remains the practical choice.

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

366,476

Score snapshot 15 Sept 2025

Apple Podcasts (US)

4.9 / 5

21 ratings

Spotify

5.0 / 5

6 ratings

Podcast Authority Score: 40 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

26

Social presence

0

YouTube

86

Engagement

51

Contact Heart Failure Beat

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.